Senkyunolide a from danggui buxue decoction protects podocytes against diabetic nephropathy via the mir-223-3p/nlrp3 inflammasome axis

毛花素 药理学 足细胞 糖尿病肾病 炎症体 汤剂 医学 黄芪 传统医学 中医药 作用机理 体内 小桶 芍药苷 当归 植物疗法 系统药理学 糖尿病 下调和上调 红景天苷 黄芪甲苷 肾病 化学 体外 信号转导 活性成分 生物活性 药用植物 药物发现 受体 离体 小檗碱 染料木素 地奥司明 机制(生物学) 信号通路
作者
Zhe Lv,Jian Yu,Dong Bian,Shuoshuo Yao,Junxia Zhang,郭登洲
出处
期刊:Journal of Ethnopharmacology [Elsevier BV]
卷期号:371: 122138-122138
标识
DOI:10.1016/j.jep.2026.122138
摘要

ETHNOPHARMACOLOGICAL RELEVANCE: Danggui Buxue Decoction (DBD), a classical Traditional Chinese Medicine (TCM) formula comprising Astragalus membranaceus (Fisch.) Bunge (Astragali Radix) and Angelica sinensis (Oliv.) Diels (Angelicae Sinensis Radix) in a 5:1 ratio, has been traditionally used to treat "Xiaoke" (wasting-thirst syndrome) and is increasingly applied as an adjunctive therapy for diabetic nephropathy (DN). DN is a major microvascular complication of diabetes mellitus for which effective curative therapies remain limited. Although DBD has demonstrated promising clinical efficacy in the prevention and management of DN, its pharmacologically active constituents and underlying mechanisms of action have yet to be fully elucidated. AIM OF THE STUDY: This study aimed to comprehensively profile the blood-entering bioactive constituents of DBD, identify the core active compound through integrated UPLC-Q-TOF-MS/MS and network pharmacology analyses, and elucidate the molecular mechanisms by which the core constituent protects against high glucose-induced podocyte injury, with particular focus on the miR-223-3p/NLRP3 inflammasome axis. MATERIALS AND METHODS: UPLC-Q-TOF-MS/MS was employed to globally characterize the chemical constituents of Danggui Buxue Decoction (DBD), and the absorbed components and in vivo metabolites were identified in a DN rat model. Network pharmacology combined with target intersection analysis was used to identify the core active constituents. Subsequently, PPI network construction, GO functional annotation, and KEGG pathway enrichment analyses were performed to elucidate the underlying molecular mechanisms. In a high glucose-induced MPC5 podocyte model, CCK-8, TUNEL, and JC-1 assays were conducted to evaluate the cytoprotective effects of the major active constituents. Furthermore, Western blotting, qRT-PCR, and dual-luciferase reporter assays were performed to clarify the regulatory mechanism of the miR-223-3p/NLRP3 axis. RESULTS: UPLC-Q-TOF-MS/MS identified a total of 1584 chemical constituents in DBD, among which 249 absorbed components and 155 in vivo metabolites were detected in the plasma of DN model rats. Network pharmacology analysis identified senkyunolide A (SA) as the core active constituent, which targeted 33 NLRP3 inflammasome-related proteins, covering the entire activation cascade of this pathway. PPI network construction and enrichment analyses further revealed that SA-associated targets were involved in key biological processes at the systems level, including oxidative stress and PI3K-Akt/NF-κB signaling pathways. In vitro experiments demonstrated that SA at a concentration of 50 μmol/L significantly ameliorated high glucose-induced podocyte injury, apoptosis, and mitochondrial dysfunction. Mechanistically, SA upregulated miR-223-3p expression, thereby directly inhibiting NLRP3 inflammasome activation, which in turn suppressed Caspase-1 cleavage and GSDMD-mediated pyroptosis. Meanwhile, SA maintained mitochondrial dynamic homeostasis and energy metabolism by regulating DRP1 phosphorylation, upregulating OPA1 and MFN2, and activating the PGC-1α/MnSOD pathway, ultimately exerting multi-level protective effects on podocytes. CONCLUSIONS: SA is identified as the core bioactive constituent of DBD responsible for its therapeutic effects in DN. SA exerts multi-level renoprotective effects by upregulating miR-223-3p, suppressing NLRP3 inflammasome activation and GSDMD-mediated pyroptosis, and maintaining mitochondrial dynamic homeostasis via the PGC-1α/MnSOD pathway. These findings provide a scientific basis for the rational application of DBD in the clinical prevention and treatment of diabetic nephropathy and highlight the miR-223-3p/NLRP3 axis as a promising therapeutic target.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
CDong完成签到 ,获得积分10
刚刚
读书人完成签到,获得积分10
刚刚
不羡完成签到,获得积分10
1秒前
1秒前
qiqiqi发布了新的文献求助10
1秒前
1秒前
bkagyin的应助被无心的谷槐采纳,获得10
2秒前
3秒前
zzk完成签到,获得积分10
3秒前
Wanfeng完成签到,获得积分10
3秒前
柠A发布了新的文献求助10
3秒前
3秒前
WilliamsR1123完成签到,获得积分10
4秒前
yi发布了新的文献求助10
4秒前
NexusExplorer的应助被corleeang采纳,获得10
4秒前
今后的应助被Lily采纳,获得10
4秒前
star完成签到,获得积分10
5秒前
5秒前
希望天下0贩的0的应助被JY采纳,获得10
5秒前
5秒前
5秒前
顾矜的应助被qin202569采纳,获得10
5秒前
温婉的篮球完成签到,获得积分10
5秒前
6秒前
绝绝紫完成签到,获得积分10
6秒前
哎哟可爱发布了新的文献求助10
6秒前
6秒前
华仔的应助被wu采纳,获得10
6秒前
7秒前
8秒前
Hing完成签到,获得积分20
8秒前
Ray发布了新的文献求助10
8秒前
脑洞疼的应助被神宝嘎li采纳,获得10
9秒前
9秒前
实验狗完成签到,获得积分10
10秒前
何胤辰完成签到,获得积分10
10秒前
温暖砖头发布了新的文献求助10
10秒前
杨自强发布了新的文献求助10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183142
求助须知:如何正确求助?哪些是违规求助? 9572420
关于积分的说明 21825253
捐赠科研通 7779922
什么是DOI,文献DOI怎么找? 3433850
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480124